Related to Fujifilm Diosynth Biotechnologies Adds 1,000 L Single Use Bioreactor to NC Site

• FDA cGMP Complaints Draw Boehringer Ingelheim Promise of Action
  
• Xcellerex, Dowpharma, Biopharm, and deltaDot Win $11M Technology Development Contract
  
• GE Healthcare to Market Fujifilm Image-Analysis Platforms Worldwide
  
• Crucell Buys Xcellerex’ Bioproduction Line and Disposable Bioreactors
  
• Novavax Taps Xcellerex to Bolster Flu Vaccine Production
  
• Xcellerex to Develop Single-Use Manufacturing Technology for Humacyte’s Vascular Grafts
  
• CMC Biologics to Manufacture ProtAffin’s Preclinical-Stage IL-8 Decoy
  
• Lonza Acquires Vivante to Expand into Viral-Based GMP Manufacturing
  
• Nitto Denko Acquires Avecia for Nucleic Acid Drug Manufacturing Capabilities
  
• Dutch Ministry Puts Public Vaccine Production Site up for Sale
  
• Enobia Chooses Lonza for Commercial-Scale Manufacture of Its Enzyme-Replacement Therapy
  
• Lonza to Provide Cell-Line and Process-Development Services for Athera’s mAb
  
• Angel Biotech to Conduct Development and Manufacturing for ReNeuron’s Stem Cell Program
  
• Fujifilm and Dr. Reddy’s Ink Pact Covering Generic Drugs in Japan
  
• ABL and MicroTest Separately Announce Contract Manufacturing Deals
  
• Sartorius Stedim, G-Con Partner to Offer Self-Contained Biomanufacturing Facilities
  
• GE Healthcare to Snag Xcellerex for Single-Use Manufacturing Technology
  
• EMD Millipore, Centre for Commercialization of Regen Med to Optimize Large-Scale Stem Cell Cultivation
  
• Agennix Contracts DSM for Commercial Supply of a Dendritic Cell Mediated Immunotherapy
  
• Agennix Contracts Lonza for Commercial Manufacturing of Its Oral NSCLC Immunotherapy